First therapy to treat rare genetic nervous system disorder AADC deficiency

View source ↗

Summary

The European Medicines Agency announces the first therapy approved to treat AADC deficiency, a rare genetic nervous system disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aromatic L-amino Acid Decarboxylase Deficiency